Figure 1. The progression of HF has been attributed mostly to LV remodeling and thought to be unrelated to the causes of LV dysfunction (A). Currently available data suggest that the factors that ...

It's the third hypertension drug we've seen recalled in a month, with scientists flagging "global safety concerns" associated with this beta-blocker. Nebivolol is the generic form of the hypertension ...

A total of 19 patients discontinued the study early (11 taking moxonidine and eight taking ramipril, respectively). 10 withdrew because of adverse effects; seven because of insufficient blood ...

Background: Data about the safety of ACEI/ARB use in early (<3 months) posttransplant period are restricted and remain controversial. Methods: This systematic review and meta-analysis included ...

Objective–To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone ...